Search results
Results from the WOW.Com Content Network
Neuro-ophthalmology is an academically-oriented subspecialty that merges the fields of neurology and ophthalmology, often dealing with complex systemic diseases that have manifestations in the visual system. Neuro-ophthalmologists initially complete a residency in either neurology or ophthalmology, then do a fellowship in the
Ophthalmology at the University of Miami School of Medicine began in 1955 and attained departmental status in 1959. [3]Bascom Palmer Eye Institute was founded seven years later, on January 20, 1962, by Edward W. D. Norton, a neuro-ophthalmologist, retinal specialist, administrator and professor who joined the University of Miami's School of Medicine with aspirations of building a regional ...
Alfredo Arrigo Sadun (born October 23, 1950) is an American ophthalmologist, academic, author and researcher. He holds the Flora L. Thornton Endowed Chair and is chief of ophthalmology at Doheny Eye Centers [1] and Vice-Chair of Ophthalmology at UCLA.
The prevalence of Functional visual loss neuro-ophthalmology clinics is said to be 5-12%, and general ophthalmology clinics 1-5%. [2] [3] It is said that the total prevalence may be much more higher because patients may also consult their general practitioners, internal medicine physicians, psychiatrists or neurologists.
Peripheral vision is usually spared since the pattern of loss typically involves a central or cecocentral scotoma, a visual field defect at or surrounding the point of fixation. This pattern can be revealed via visual field testing. Upon examination, the pupils usually demonstrate a normal response to light and near stimulation. In those who ...
Optic neuropathy is damage to the optic nerve from any cause. The optic nerve is a bundle of millions of fibers in the retina that sends visual signals to the brain. Damage and death of these nerve cells, or neurons, leads to characteri
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
Some reports point to the metalloproteinase-2 and interleukin-6 as culprits responsible for the BBB failure. [22] There is broad consensus that AQP4/NMO-IgG initially enters the brain via BBB-deficient sites such as the area postrema, where there is access to cerebrospinal fluid (CSF). [23] In any case, anti-AQP4 is produced mainly ...